Regeneron Pharmaceuticals and CytomX have expanded their research and licensing partnership to develop conditionally activated bispecific antibody cancer therapies.The post...
Moonlight Therapeutics has begun the SURVEYOR Phase I clinical trial to assess MOON101, an investigational immunotherapy for peanut allergy.The post...
The US FDA has accepted priority review of the NDA for Roche’s investigational oral SERD, giredestrant, for breast cancer.The post...
Philips has received 510(k) clearance for Elevate Plus, which adds imaging and AI capabilities to its EPIQ Elite and Affiniti...
Jade Biosciences has reported positive interim data from its Phase I trial studying JADE101, an investigational anti-APRIL monoclonal antibody for...
MicroPort CardioFlow has commercially launched its LBBOT Solution in Europe and Australia after obtaining the required regulatory approvals.The post MicroPort...
Servier has signed an agreement to acquire Edgewise Therapeutics’ muscular dystrophy business in a deal valued at up to $2.65bn.The...
South Korean medical technology company SKIA has received FDA 510(k) clearance for its SKIA HEAD, its AR surgical guidance system.The...
AstraZeneca has secured FDA approval for Imfinzi in combination with BCG induction and maintenance therapy for adults with BCG-naïve, high-risk...
Whether you are a professional looking for a new job or a representative of an organization who needs workforce solutions - we are here to help.